Drybench Patent.

Patent and exclusivity dates from January to June 2033 for NDAs, as FDA's Orange Book lists them

Each patent and exclusivity date from January to June 2033 that FDA's Orange Book lists for an NDA, as captured on 14 October 2026. That capture lists a patent or exclusivity for 1,411 NDAs. Each entry is named by its rule and linked to its NDA page. A date here belongs to one patent or one exclusivity on the products named; the same NDA may have other listed dates, earlier or later, so no date here stands for a product.

FDA capture · review pending. Each date is shown as captured from FDA's Orange Book files. Dates are as FDA lists them, and Drybench computes none; patent dates are submitted by the applicant, and FDA does not verify them. Spreadsheet day numbers are shown as dates; a cell that cannot be read as one date is left off this page and shown as written on its NDA page. Where FDA lists a *PED row without flags, its flags are read from the base row and marked so. How this page reads FDA's files has not been independently reviewed by a regulatory-affairs reviewer.

Orange Book captured: 14 October 2026

Listed protection is a range of the dates FDA lists, not a forecast of market entry, and not legal, regulatory or investment advice.

This page covers every NDA whose Orange Book capture lists a patent or exclusivity. It does not cover ANDAs or any BLA. NCE exclusivity dates are here as FDA lists them; NCE-1 dates, computed from them, are on the NCE-1 calendar.

Dates as listed in FDA's Orange Book capture of 14 October 2026. This page does not say whether a date has passed; compare it with today's date and FDA's current Orange Book. This page shows only what the capture of 14 October 2026 lists. It does not show patents or exclusivities listed before and since removed.

NCE-1, one year before a listed NCE exclusivity date and the one date Drybench computes, is on its own page: NCE-1 dates from the Orange Book

Listed dates, 2033 July to December 2033

Listed patent expiry (413)

2 Jan 2033 · NDA 205103 · ASPIRIN; OMEPRAZOLE
US 9,987,231, use patent
patent.txt lines 5,204, 5,206
Flags
use code U-2324
Product numbers
001, 002
2 Jan 2033 · NDA 208400 · METHOTREXATE SODIUM
US 10,231,927, use patent
patent.txt line 8,572
Flags
use code U-1349
Product numbers
001
2 Jan 2033 · NDA 208400 · METHOTREXATE SODIUM
US 10,231,927, use patent
patent.txt line 8,573
Flags
use code U-1699
Product numbers
001
2 Jan 2033 · NDA 208400 · METHOTREXATE SODIUM
US 10,610,485, product patent
patent.txt line 8,574
Flags
product
Product numbers
001
2 Jan 2033 · NDA 208400 · METHOTREXATE SODIUM
US 11,116,724, use patent
patent.txt line 8,575
Flags
use code U-1349
Product numbers
001
2 Jan 2033 · NDA 208400 · METHOTREXATE SODIUM
US 11,116,724, use patent
patent.txt line 8,576
Flags
use code U-1699
Product numbers
001
2 Jan 2033 · NDA 208400 · METHOTREXATE SODIUM
US 11,969,503, product patent
patent.txt line 8,577
Flags
product
Product numbers
001
2 Jan 2033 · NDA 208400 · METHOTREXATE SODIUM
US 12,396,947, product patent
patent.txt line 8,578
Flags
product
Product numbers
001
2 Jan 2033 · NDA 208400 · METHOTREXATE SODIUM
US 9,259,427, product patent
patent.txt line 8,579
Flags
product
Product numbers
001
2 Jan 2033 · NDA 208400 · METHOTREXATE SODIUM
US 9,855,215, product patent
patent.txt line 8,580
Flags
product
Product numbers
001
4 Jan 2033 · NDA 205060 · OMEGA-3-CARBOXYLIC ACIDS
US 10,117,844, use patent
patent.txt line 5,193
Flags
use code U-2447
Product numbers
001
4 Jan 2033 · NDA 205060 · OMEGA-3-CARBOXYLIC ACIDS
US 9,050,308, use patent
patent.txt line 5,195
Flags
use code U-1511
Product numbers
001
4 Jan 2033 · NDA 205060 · OMEGA-3-CARBOXYLIC ACIDS
US 9,050,309, substance patent
patent.txt line 5,196
Flags
substance
Product numbers
001
7 Jan 2033 · NDA 209606 · ENASIDENIB MESYLATE
US 10,294,215, product and use patent
patent.txt lines 10,663, 10,669
Flags
product use code U-2087
Product numbers
001, 002
7 Jan 2033 · NDA 209606 · ENASIDENIB MESYLATE
US 9,512,107, substance and product and use patent
patent.txt lines 10,665, 10,671
Flags
substance product use code U-2087
Product numbers
001, 002
9 Jan 2033 · NDA 209511 · BUPIVACAINE HYDROCHLORIDE
US 11,746,141, product patent
patent.txt line 10,587
Flags
product
Product numbers
001
10 Jan 2033 · NDA 213876 · HYDROCORTISONE
US 9,675,559, use patent
patent.txt lines 15,287, 15,290, 15,293, 15,296
Flags
use code U-3075
Product numbers
001, 002, 003, 004
11 Jan 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 10,195,168, product patent
patent.txt line 14,344
Flags
product
Product numbers
001
11 Jan 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 10,675,258, use patent
patent.txt line 14,347
Flags
use code U-2938
Product numbers
001
11 Jan 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 11,554,102, product patent
patent.txt line 14,354
Flags
product
Product numbers
001
11 Jan 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 8,591,922, product patent
patent.txt line 14,359
Flags
product
Product numbers
001
11 Jan 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 8,901,173, product patent
patent.txt line 14,363
Flags
product
Product numbers
001
11 Jan 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 9,132,107, product patent
patent.txt line 14,366
Flags
product
Product numbers
001
13 Jan 2033 · NDA 215014 · PEGCETACOPLAN
US 11,661,441, substance and use patent
patent.txt line 16,429
Flags
substance use code U-3124
Product numbers
001
13 Jan 2033 · NDA 215014 · PEGCETACOPLAN
US 11,661,441, substance and use patent
patent.txt line 16,430
Flags
substance use code U-4242
Product numbers
001
13 Jan 2033 · NDA 217171 · PEGCETACOPLAN
US 11,661,441, substance and use patent
patent.txt line 19,277
Flags
substance use code U-3540
Product numbers
001
14 Jan 2033 · NDA 202123 · EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE
US 10,857,102, product patent
patent.txt line 2,774
Flags
product
Product numbers
001
16 Jan 2033 · NDA 201848 · MELPHALAN HYDROCHLORIDE
US 10,195,334, product patent
patent.txt line 2,585
Flags
product
Product numbers
001
18 Jan 2033 · NDA 211192 · IVOSIDENIB
US 10,717,764, use patent
patent.txt line 12,515
Flags
use code U-3215
Product numbers
001
18 Jan 2033 · NDA 211192 · IVOSIDENIB
US 11,667,673, use patent
patent.txt line 12,524
Flags
use code U-3742
Product numbers
001
18 Jan 2033 · NDA 211192 · IVOSIDENIB
US 9,850,277, substance and product and use patent
patent.txt line 12,531
Flags
substance product use code U-2350
Product numbers
001
18 Jan 2033 · NDA 211192 · IVOSIDENIB
US 9,850,277, substance and product and use patent
patent.txt line 12,532
Flags
substance product use code U-2533
Product numbers
001
18 Jan 2033 · NDA 211192 · IVOSIDENIB
US 9,850,277, substance and product and use patent
patent.txt line 12,533
Flags
substance product use code U-2534
Product numbers
001
18 Jan 2033 · NDA 211192 · IVOSIDENIB
US 9,850,277, substance and product and use patent
patent.txt line 12,534
Flags
substance product use code U-3213
Product numbers
001
18 Jan 2033 · NDA 211192 · IVOSIDENIB
US 9,850,277, substance and product and use patent
patent.txt line 12,535
Flags
substance product use code U-3386
Product numbers
001
18 Jan 2033 · NDA 211192 · IVOSIDENIB
US 9,850,277, substance and product and use patent
patent.txt line 12,536
Flags
substance product use code U-3742
Product numbers
001
20 Jan 2033 · NDA 210797 · AFAMELANOTIDE
US 8,334,265, use patent
patent.txt line 12,151
Flags
use code U-2638
Product numbers
001
23 Jan 2033 · NDA 211371 · BREXANOLONE
US 10,322,139, product patent
patent.txt line 12,858
Flags
product
Product numbers
001
23 Jan 2033 · NDA 213436 · DIHYDROERGOTAMINE MESYLATE
US 10,940,278, product patent
patent.txt line 15,014
Flags
product
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 10,149,829, use patent
patent.txt line 5,761
Flags
use code U-2477
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 10,149,829, use patent
patent.txt line 5,762
Flags
use code U-3006
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 10,449,176, use patent
patent.txt line 5,766
Flags
use code U-2149
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 10,610,510, use patent
patent.txt line 5,767
Flags
use code U-2805
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 10,610,510, use patent
patent.txt line 5,768
Flags
use code U-3009
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 10,945,988, use patent
patent.txt line 5,772
Flags
use code U-2149
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 10,980,770, use patent
patent.txt line 5,773
Flags
use code U-3106
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 10,980,770, use patent
patent.txt line 5,774
Flags
use code U-3107
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 11,285,129, use patent
patent.txt line 5,778
Flags
use code U-3342
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 11,285,129, use patent
patent.txt line 5,779
Flags
use code U-3343
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 11,633,377, use patent
patent.txt line 5,781
Flags
use code U-2149
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 11,633,377, use patent
patent.txt line 5,782
Flags
use code U-3003
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 11,826,339, use patent
patent.txt line 5,787
Flags
use code U-3342
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 11,826,339, use patent
patent.txt line 5,788
Flags
use code U-3343
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 11,833,130, use patent
patent.txt line 5,789
Flags
use code U-2149
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 11,833,130, use patent
patent.txt line 5,790
Flags
use code U-3003
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 11,850,229, use patent
patent.txt line 5,791
Flags
use code U-3342
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 11,850,229, use patent
patent.txt line 5,792
Flags
use code U-3343
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 11,918,557, use patent
patent.txt line 5,795
Flags
use code U-3003
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 11,918,557, use patent
patent.txt line 5,796
Flags
use code U-3865
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 12,201,604, use patent
patent.txt line 5,798
Flags
use code U-3003
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 12,201,604, use patent
patent.txt line 5,799
Flags
use code U-3865
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 9,060,995, use patent
patent.txt line 5,800
Flags
use code U-1710
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 9,539,234, use patent
patent.txt line 5,801
Flags
use code U-1934
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 9,539,234, use patent
patent.txt line 5,802
Flags
use code U-3004
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 9,549,913, use patent
patent.txt line 5,803
Flags
use code U-1486
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 9,855,241, use patent
patent.txt line 5,806
Flags
use code U-2149
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US RE46604, use patent
patent.txt line 5,807
Flags
use code U-2147
Product numbers
001
25 Jan 2033 · NDA 214517 · TASIMELTEON
US 10,149,829, use patent
patent.txt line 15,836
Flags
use code U-3006
Product numbers
001
25 Jan 2033 · NDA 214517 · TASIMELTEON
US 10,610,510, use patent
patent.txt line 15,839
Flags
use code U-3009
Product numbers
001
25 Jan 2033 · NDA 214517 · TASIMELTEON
US 10,980,770, use patent
patent.txt line 15,842
Flags
use code U-3106
Product numbers
001
25 Jan 2033 · NDA 214517 · TASIMELTEON
US 11,285,129, use patent
patent.txt line 15,846
Flags
use code U-3342
Product numbers
001
25 Jan 2033 · NDA 214517 · TASIMELTEON
US 11,633,377, use patent
patent.txt line 15,848
Flags
use code U-3003
Product numbers
001
25 Jan 2033 · NDA 214517 · TASIMELTEON
US 11,826,339, use patent
patent.txt line 15,852
Flags
use code U-3342
Product numbers
001
25 Jan 2033 · NDA 214517 · TASIMELTEON
US 11,833,130, use patent
patent.txt line 15,853
Flags
use code U-3003
Product numbers
001
25 Jan 2033 · NDA 214517 · TASIMELTEON
US 11,850,229, use patent
patent.txt line 15,854
Flags
use code U-3342
Product numbers
001
25 Jan 2033 · NDA 214517 · TASIMELTEON
US 11,918,557, use patent
patent.txt line 15,856
Flags
use code U-3003
Product numbers
001
25 Jan 2033 · NDA 214517 · TASIMELTEON
US 12,201,604, use patent
patent.txt line 15,858
Flags
use code U-3003
Product numbers
001
25 Jan 2033 · NDA 214517 · TASIMELTEON
US 9,539,234, use patent
patent.txt line 15,860
Flags
use code U-3004
Product numbers
001
31 Jan 2033 · NDA 204286 · NAFTIFINE HYDROCHLORIDE
US 10,166,205, product patent
patent.txt line 4,455
Flags
product
Product numbers
001
31 Jan 2033 · NDA 204286 · NAFTIFINE HYDROCHLORIDE
US 10,166,206, product patent
patent.txt line 4,456
Flags
product
Product numbers
001
31 Jan 2033 · NDA 204286 · NAFTIFINE HYDROCHLORIDE
US 10,695,303, product patent
patent.txt line 4,457
Flags
product
Product numbers
001
31 Jan 2033 · NDA 204286 · NAFTIFINE HYDROCHLORIDE
US 10,729,667, product patent
patent.txt line 4,458
Flags
product
Product numbers
001
31 Jan 2033 · NDA 204286 · NAFTIFINE HYDROCHLORIDE
US 8,778,365, product patent
patent.txt line 4,459
Flags
product
Product numbers
001
31 Jan 2033 · NDA 204286 · NAFTIFINE HYDROCHLORIDE
US 9,161,914, use patent
patent.txt line 4,460
Flags
use code U-540
Product numbers
001
3 Feb 2033 · NDA 021338 · FENTANYL HYDROCHLORIDE
US 9,095,706, product patent
patent.txt line 552
Flags
product
Product numbers
001
4 Feb 2033 · NDA 219878 · BAXDROSTAT
US 9,353,081, substance and product patent
patent.txt lines 22,035–22,036
Flags
substance product
Product numbers
001, 002
7 Feb 2033 · NDA 211964 · VILOXAZINE HYDROCHLORIDE
US 9,358,204, product patent
patent.txt lines 13,295, 13,301, 13,307
Flags
product
Product numbers
001, 002, 003
7 Feb 2033 · NDA 211964 · VILOXAZINE HYDROCHLORIDE
US 9,603,853, use patent
patent.txt lines 13,296, 13,302, 13,308
Flags
use code U-727
Product numbers
001, 002, 003
8 Feb 2033 · NDA 213535 · RISDIPLAM
US 9,586,955, substance and product patent
patent.txt line 15,085
Flags
substance product
Product numbers
001
8 Feb 2033 · NDA 219285 · RISDIPLAM
US 9,586,955, substance and product patent
patent.txt line 21,576
Flags
substance product
Product numbers
001
9 Feb 2033 · NDA 209521 · SARECYCLINE HYDROCHLORIDE
US 9,255,068, substance and product and use patent
patent.txt lines 10,591, 10,596, 10,601
Flags
substance product use code U-2407
Product numbers
001, 002, 003
9 Feb 2033 · NDA 209521 · SARECYCLINE HYDROCHLORIDE
US 9,255,068, substance and product and use patent
patent.txt lines 10,592, 10,597, 10,602
Flags
substance product use code U-2408
Product numbers
001, 002, 003
13 Feb 2033 · NDA 214801 · FUTIBATINIB
US 9,108,973, substance and product and use patent
patent.txt lines 16,200, 16,203
Flags
substance product use code U-3456
Product numbers
001, 002
18 Feb 2033 · NDA 209661 · DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE
US 9,089,489, product and use patent
patent.txt line 10,778
Flags
product use code U-1382
Product numbers
001
18 Feb 2033 · NDA 209661 · DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE
US 9,375,404, product and use patent
patent.txt line 10,779
Flags
product use code U-1382
Product numbers
001
18 Feb 2033 · NDA 209661 · DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE
US 9,526,703, product and use patent
patent.txt line 10,780
Flags
product use code U-1382
Product numbers
001
18 Feb 2033 · NDA 209661 · DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE
US 9,937,132, product and use patent
patent.txt line 10,781
Flags
product use code U-1382
Product numbers
001
25 Feb 2033 · NDA 212728 · RIMEGEPANT SULFATE
US 8,759,372, substance and product patent
patent.txt line 14,411
Flags
substance product
Product numbers
001
27 Feb 2033 · NDA 022325 · AMIODARONE HYDROCHLORIDE
US 9,493,582, product patent
patent.txt lines 1,696, 1,702
Flags
product
Product numbers
002, 003
27 Feb 2033 · NDA 202714 · CARFILZOMIB
US 9,493,582, product patent
patent.txt lines 3,143, 3,153, 3,163
Flags
product
Product numbers
001, 002, 003
27 Feb 2033 · NDA 205596 · POSACONAZOLE
US 9,493,582, product patent
patent.txt line 5,694
Flags
product
Product numbers
001
27 Feb 2033 · NDA 206030 · CARBAMAZEPINE
US 9,493,582, product patent
patent.txt line 6,073
Flags
product
Product numbers
001
27 Feb 2033 · NDA 207155 · MELPHALAN HYDROCHLORIDE
US 9,493,582, product patent
patent.txt line 7,061
Flags
product
Product numbers
001
27 Feb 2033 · NDA 207925 · IVACAFTOR
US 10,272,046, product and use patent
patent.txt lines 7,492, 7,525
Flags
product use code U-2531
Product numbers
001, 002
27 Feb 2033 · NDA 207925 · IVACAFTOR
US 10,272,046, product and use patent
patent.txt line 7,558
Flags
product use code U-2967
Product numbers
003
27 Feb 2033 · NDA 207925 · IVACAFTOR
US 10,272,046, product and use patent
patent.txt lines 7,591, 7,619
Flags
product use code U-3605
Product numbers
004, 005
27 Feb 2033 · NDA 207925 · IVACAFTOR
US 11,147,770, product and use patent
patent.txt lines 7,496, 7,529, 7,562
Flags
product use code U-3339
Product numbers
001, 002, 003
27 Feb 2033 · NDA 207925 · IVACAFTOR
US 11,147,770, product and use patent
patent.txt lines 7,595, 7,623
Flags
product use code U-3604
Product numbers
004, 005
27 Feb 2033 · NDA 207925 · IVACAFTOR
US 11,752,106, product and use patent
patent.txt lines 7,500, 7,533, 7,566, 7,599, 7,627
Flags
product use code U-3697
Product numbers
001, 002, 003, 004, 005
27 Feb 2033 · NDA 207925 · IVACAFTOR
US 12,214,083, product and use patent
patent.txt lines 7,502, 7,535
Flags
product use code U-4126
Product numbers
001, 002
27 Feb 2033 · NDA 207925 · IVACAFTOR
US 12,214,083, product and use patent
patent.txt line 7,568
Flags
product use code U-4128
Product numbers
003
27 Feb 2033 · NDA 207925 · IVACAFTOR
US 12,214,083, product and use patent
patent.txt lines 7,601, 7,629
Flags
product use code U-4127
Product numbers
004, 005
27 Feb 2033 · NDA 207925 · IVACAFTOR
US 8,883,206, product patent
patent.txt lines 7,520, 7,553, 7,586, 7,615, 7,643
Flags
product
Product numbers
001, 002, 003, 004, 005
27 Feb 2033 · NDA 208611 · DELAFLOXACIN MEGLUMINE
US 9,493,582, product patent
patent.txt line 8,923
Flags
product
Product numbers
001
27 Feb 2033 · NDA 210864 · FOSPHENYTOIN SODIUM
US 9,493,582, product patent
patent.txt lines 12,252, 12,257
Flags
product
Product numbers
001, 002
27 Feb 2033 · NDA 217660 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US 10,272,046, product and use patent
patent.txt lines 20,069, 20,142
Flags
product use code U-3599
Product numbers
001, 002
27 Feb 2033 · NDA 217660 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US 10,272,046, product and use patent
patent.txt lines 20,070, 20,143
Flags
product use code U-4062
Product numbers
001, 002
27 Feb 2033 · NDA 217660 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US 10,272,046, product and use patent
patent.txt lines 20,071, 20,144
Flags
product use code U-4482
Product numbers
001, 002
27 Feb 2033 · NDA 217660 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US 11,147,770, product and use patent
patent.txt lines 20,079, 20,152
Flags
product use code U-3598
Product numbers
001, 002
27 Feb 2033 · NDA 217660 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US 11,147,770, product and use patent
patent.txt lines 20,080, 20,153
Flags
product use code U-4060
Product numbers
001, 002
27 Feb 2033 · NDA 217660 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US 11,147,770, product and use patent
patent.txt lines 20,081, 20,154
Flags
product use code U-4483
Product numbers
001, 002
27 Feb 2033 · NDA 217660 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US 11,752,106, product and use patent
patent.txt lines 20,101, 20,174
Flags
product use code U-3696
Product numbers
001, 002
27 Feb 2033 · NDA 217660 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US 11,752,106, product and use patent
patent.txt lines 20,102, 20,175
Flags
product use code U-4052
Product numbers
001, 002
27 Feb 2033 · NDA 217660 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US 11,752,106, product and use patent
patent.txt lines 20,103, 20,176
Flags
product use code U-4489
Product numbers
001, 002
27 Feb 2033 · NDA 217660 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US 12,214,083, product and use patent
patent.txt lines 20,104, 20,177
Flags
product use code U-4141
Product numbers
001, 002
27 Feb 2033 · NDA 217660 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US 12,214,083, product and use patent
patent.txt lines 20,105, 20,178
Flags
product use code U-4492
Product numbers
001, 002
27 Feb 2033 · NDA 217660 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US 8,883,206, product patent
patent.txt lines 20,124, 20,199
Flags
product
Product numbers
001, 002
28 Feb 2033 · NDA 206356 · NITISINONE
US 9,301,932, product and use patent
patent.txt line 6,496
Flags
product use code U-1836
Product numbers
001
28 Feb 2033 · NDA 209940 · LETERMOVIR
US 10,603,384, product patent
patent.txt lines 11,066, 11,068
Flags
product
Product numbers
001, 002
28 Feb 2033 · NDA 210361 · GLYCOPYRRONIUM TOSYLATE
US 10,004,717, product and use patent
patent.txt line 11,311
Flags
product use code U-2398
Product numbers
001
28 Feb 2033 · NDA 210361 · GLYCOPYRRONIUM TOSYLATE
US 10,543,192, product patent
patent.txt line 11,313
Flags
product
Product numbers
001
28 Feb 2033 · NDA 210361 · GLYCOPYRRONIUM TOSYLATE
US 10,548,875, substance and product and use patent
patent.txt line 11,314
Flags
substance product use code U-2398
Product numbers
001
28 Feb 2033 · NDA 210361 · GLYCOPYRRONIUM TOSYLATE
US 8,859,610, product and use patent
patent.txt line 11,316
Flags
product use code U-2398
Product numbers
001
28 Feb 2033 · NDA 210361 · GLYCOPYRRONIUM TOSYLATE
US 9,259,414, use patent
patent.txt line 11,317
Flags
use code U-2398
Product numbers
001
1 Mar 2033 · NDA 219685 · RILZABRUTINIB
US 9,580,427, substance and product patent
patent.txt line 21,868
Flags
substance product
Product numbers
001
5 Mar 2033 · NDA 202107 · MIFEPRISTONE
US 10,500,216, use patent
patent.txt line 2,764
Flags
use code U-1643
Product numbers
001
5 Mar 2033 · NDA 205858 · IDELALISIB
US 10,730,879, substance and product patent
patent.txt lines 5,988, 5,992
Flags
substance product
Product numbers
001, 002
5 Mar 2033 · NDA 205858 · IDELALISIB
US 8,865,730, substance and product and use patent
patent.txt lines 5,989, 5,993
Flags
substance product use code U-1615
Product numbers
001, 002
5 Mar 2033 · NDA 210868 · LORLATINIB
US 8,680,111, substance and product patent
patent.txt lines 12,263, 12,268
Flags
substance product
Product numbers
001, 002
5 Mar 2033 · NDA 211243 · ESKETAMINE HYDROCHLORIDE
US 8,785,500, use patent
patent.txt line 12,659
Flags
use code U-2502
Product numbers
001
5 Mar 2033 · NDA 211243 · ESKETAMINE HYDROCHLORIDE
US 8,785,500, use patent
patent.txt line 12,660
Flags
use code U-4112
Product numbers
001
6 Mar 2033 · NDA 208026 · LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 9,555,001, product and use patent
patent.txt lines 7,989, 8,008
Flags
product use code U-1967
Product numbers
001, 002
6 Mar 2033 · NDA 208026 · LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 9,555,001, product and use patent
patent.txt lines 7,990, 8,009
Flags
product use code U-1968
Product numbers
001, 002
7 Mar 2033 · NDA 215211 · MIGLUSTAT
US 10,512,677, use patent
patent.txt line 16,581
Flags
use code U-3726
Product numbers
001
7 Mar 2033 · NDA 215211 · MIGLUSTAT
US 11,278,599, use patent
patent.txt line 16,584
Flags
use code U-3726
Product numbers
001
7 Mar 2033 · NDA 215211 · MIGLUSTAT
US 12,419,937, use patent
patent.txt line 16,589
Flags
use code U-3726
Product numbers
001
7 Mar 2033 · NDA 215239 · VAMOROLONE
US 11,690,853, use patent
patent.txt line 16,593
Flags
use code U-3747
Product numbers
001
9 Mar 2033 · NDA 204958 · CANGRELOR
US 8,680,052, use patent
patent.txt line 5,183
Flags
use code U-2979
Product numbers
001
13 Mar 2033 · NDA 205103 · ASPIRIN; OMEPRAZOLE
US 9,539,214, use patent
patent.txt lines 5,203, 5,205
Flags
use code U-1902
Product numbers
001, 002
13 Mar 2033 · NDA 215206 · ATOGEPANT
US 9,850,246, substance patent
patent.txt lines 16,566, 16,573, 16,579
Flags
substance
Product numbers
001, 002, 003
14 Mar 2033 · NDA 206940 · ELUXADOLINE
US 10,188,632, product patent
patent.txt lines 6,846, 6,860
Flags
product
Product numbers
001, 002
14 Mar 2033 · NDA 206940 · ELUXADOLINE
US 11,007,179, product patent
patent.txt lines 6,847, 6,861
Flags
product
Product numbers
001, 002
14 Mar 2033 · NDA 206940 · ELUXADOLINE
US 11,090,291, product patent
patent.txt lines 6,848, 6,862
Flags
product
Product numbers
001, 002
14 Mar 2033 · NDA 206940 · ELUXADOLINE
US 11,160,792, product patent
patent.txt lines 6,849, 6,863
Flags
product
Product numbers
001, 002
14 Mar 2033 · NDA 206940 · ELUXADOLINE
US 11,229,627, product patent
patent.txt lines 6,850, 6,864
Flags
product
Product numbers
001, 002
14 Mar 2033 · NDA 206940 · ELUXADOLINE
US 11,311,516, product patent
patent.txt lines 6,851, 6,865
Flags
product
Product numbers
001, 002
14 Mar 2033 · NDA 206940 · ELUXADOLINE
US 11,484,527, use patent
patent.txt line 6,866
Flags
use code U-3475
Product numbers
002
14 Mar 2033 · NDA 206940 · ELUXADOLINE
US 12,097,187, use patent
patent.txt line 6,852
Flags
use code U-3475
Product numbers
001
14 Mar 2033 · NDA 206940 · ELUXADOLINE
US 9,675,587, product patent
patent.txt lines 6,857, 6,871
Flags
product
Product numbers
001, 002
14 Mar 2033 · NDA 217417 · REZAFUNGIN ACETATE
US 10,702,573, substance and product and use patent
patent.txt line 19,916
Flags
substance product use code U-3566
Product numbers
001
14 Mar 2033 · NDA 217417 · REZAFUNGIN ACETATE
US 9,526,835, substance and product and use patent
patent.txt line 19,922
Flags
substance product use code U-3566
Product numbers
001
15 Mar 2033 · NDA 021196 · SODIUM OXYBATE
US 10,213,400, use patent
patent.txt line 490
Flags
use code U-2499
Product numbers
001
15 Mar 2033 · NDA 021196 · SODIUM OXYBATE
US 10,864,181, use patent
patent.txt line 492
Flags
use code U-1532
Product numbers
001
15 Mar 2033 · NDA 021196 · SODIUM OXYBATE
US 11,253,494, use patent
patent.txt line 494
Flags
use code U-3323
Product numbers
001
15 Mar 2033 · NDA 021196 · SODIUM OXYBATE
US 11,253,494, use patent
patent.txt line 495
Flags
use code U-3324
Product numbers
001
15 Mar 2033 · NDA 021196 · SODIUM OXYBATE
US 11,986,446, use patent
patent.txt line 496
Flags
use code U-3324
Product numbers
001
15 Mar 2033 · NDA 021196 · SODIUM OXYBATE
US 8,772,306, use patent
patent.txt line 498
Flags
use code U-1532
Product numbers
001
15 Mar 2033 · NDA 021196 · SODIUM OXYBATE
US 9,050,302, use patent
patent.txt line 500
Flags
use code U-1532
Product numbers
001
15 Mar 2033 · NDA 021196 · SODIUM OXYBATE
US 9,486,426, use patent
patent.txt line 502
Flags
use code U-1532
Product numbers
001
15 Mar 2033 · NDA 205703 · ESMOLOL HYDROCHLORIDE
US 8,829,054, product patent
patent.txt lines 5,808, 5,810
Flags
product
Product numbers
001, 002
15 Mar 2033 · NDA 205703 · ESMOLOL HYDROCHLORIDE
US 8,835,505, product patent
patent.txt lines 5,809, 5,811
Flags
product
Product numbers
001, 002
15 Mar 2033 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 10,052,385, use patent
patent.txt line 8,299
Flags
use code U-1971
Product numbers
001
15 Mar 2033 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 10,052,385, use patent
patent.txt line 8,300
Flags
use code U-1972
Product numbers
001
15 Mar 2033 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 9,000,021, use patent
patent.txt line 8,313
Flags
use code U-1542
Product numbers
001
15 Mar 2033 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 9,034,908, use patent
patent.txt line 8,314
Flags
use code U-1542
Product numbers
001
15 Mar 2033 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 9,144,568, use patent
patent.txt line 8,315
Flags
use code U-1542
Product numbers
001
15 Mar 2033 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 9,572,887, use patent
patent.txt line 8,321
Flags
use code U-1971
Product numbers
001
15 Mar 2033 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 9,572,887, use patent
patent.txt line 8,322
Flags
use code U-1972
Product numbers
001
15 Mar 2033 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 9,579,384, use patent
patent.txt line 8,323
Flags
use code U-1971
Product numbers
001
15 Mar 2033 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 9,579,384, use patent
patent.txt line 8,324
Flags
use code U-1972
Product numbers
001
15 Mar 2033 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 9,597,397, use patent
patent.txt line 8,325
Flags
use code U-1971
Product numbers
001
15 Mar 2033 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 9,597,397, use patent
patent.txt line 8,326
Flags
use code U-1972
Product numbers
001
15 Mar 2033 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 9,597,398, use patent
patent.txt line 8,327
Flags
use code U-1971
Product numbers
001
15 Mar 2033 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 9,597,399, use patent
patent.txt line 8,328
Flags
use code U-1971
Product numbers
001
15 Mar 2033 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 9,597,399, use patent
patent.txt line 8,329
Flags
use code U-1972
Product numbers
001
15 Mar 2033 · NDA 208352 · CITRIC ACID; LACTIC ACID; POTASSIUM BITARTRATE
US 10,568,855, use patent
patent.txt line 8,547
Flags
use code U-1
Product numbers
001
15 Mar 2033 · NDA 208352 · CITRIC ACID; LACTIC ACID; POTASSIUM BITARTRATE
US 11,337,989, use patent
patent.txt line 8,548
Flags
use code U-1
Product numbers
001
15 Mar 2033 · NDA 208352 · CITRIC ACID; LACTIC ACID; POTASSIUM BITARTRATE
US 11,439,610, substance and product patent
patent.txt line 8,549
Flags
substance product
Product numbers
001
15 Mar 2033 · NDA 208352 · CITRIC ACID; LACTIC ACID; POTASSIUM BITARTRATE
US 11,992,472, use patent
patent.txt line 8,550
Flags
use code U-1
Product numbers
001
15 Mar 2033 · NDA 212194 · GIVOSIRAN SODIUM
US 10,125,364, substance and product and use patent
patent.txt line 13,615
Flags
substance product use code U-2672
Product numbers
001
15 Mar 2033 · NDA 212194 · GIVOSIRAN SODIUM
US 9,631,193, use patent
patent.txt line 13,621
Flags
use code U-2672
Product numbers
001
15 Mar 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 10,213,400, use patent
patent.txt line 14,346
Flags
use code U-2499
Product numbers
001
15 Mar 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 10,864,181, use patent
patent.txt line 14,349
Flags
use code U-3017
Product numbers
001
15 Mar 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 11,253,494, use patent
patent.txt line 14,351
Flags
use code U-3323
Product numbers
001
15 Mar 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 11,253,494, use patent
patent.txt line 14,352
Flags
use code U-3324
Product numbers
001
15 Mar 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 11,986,446, use patent
patent.txt line 14,355
Flags
use code U-3017
Product numbers
001
15 Mar 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 11,986,446, use patent
patent.txt line 14,356
Flags
use code U-3324
Product numbers
001
15 Mar 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 8,772,306, use patent
patent.txt line 14,361
Flags
use code U-1532
Product numbers
001
15 Mar 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 8,772,306, use patent
patent.txt line 14,362
Flags
use code U-3198
Product numbers
001
15 Mar 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 9,050,302, use patent
patent.txt line 14,365
Flags
use code U-1532
Product numbers
001
15 Mar 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 9,486,426, use patent
patent.txt line 14,368
Flags
use code U-1532
Product numbers
001
15 Mar 2033 · NDA 213051 · SEMAGLUTIDE
US 10,933,120, product patent
patent.txt lines 14,581, 14,596, 14,611
Flags
product
Product numbers
001, 002, 003
15 Mar 2033 · NDA 213051 · SEMAGLUTIDE
US 11,759,501, product patent
patent.txt lines 14,585, 14,600, 14,615
Flags
product
Product numbers
001, 002, 003
15 Mar 2033 · NDA 213051 · SEMAGLUTIDE
US 11,759,502, product patent
patent.txt lines 14,586, 14,601, 14,616
Flags
product
Product numbers
001, 002, 003
15 Mar 2033 · NDA 213051 · SEMAGLUTIDE
US 11,759,503, product patent
patent.txt lines 14,587, 14,602, 14,617
Flags
product
Product numbers
001, 002, 003
15 Mar 2033 · NDA 213051 · SEMAGLUTIDE
US 12,594,326, product patent
patent.txt lines 14,590, 14,605, 14,620
Flags
product
Product numbers
001, 002, 003
15 Mar 2033 · NDA 213953 · TESTOSTERONE UNDECANOATE
US 11,617,758, product and use patent
patent.txt lines 15,330, 15,336, 15,342
Flags
product use code U-2506
Product numbers
001, 002, 003
15 Mar 2033 · NDA 213953 · TESTOSTERONE UNDECANOATE
US 12,357,643, product and use patent
patent.txt lines 15,331, 15,337, 15,343
Flags
product use code U-2506
Product numbers
001, 002, 003
15 Mar 2033 · NDA 217779 · IMETELSTAT SODIUM
US 12,442,000, use patent
patent.txt lines 20,361, 20,367
Flags
use code U-3956
Product numbers
001, 002
15 Mar 2033 · NDA 217779 · IMETELSTAT SODIUM
US 9,375,485, use patent
patent.txt lines 20,363, 20,369
Flags
use code U-3956
Product numbers
001, 002
15 Mar 2033 · NDA 219019 · FITUSIRAN SODIUM
US 9,376,680, substance and product and use patent
patent.txt lines 21,461, 21,465
Flags
substance product use code U-4165
Product numbers
001, 002
17 Mar 2033 · NDA 213436 · DIHYDROERGOTAMINE MESYLATE
US 9,919,117, product and use patent
patent.txt line 15,018
Flags
product use code U-3218
Product numbers
001
19 Mar 2033 · NDA 205122 · TOPIRAMATE
US 10,363,224, use patent
patent.txt lines 5,237, 5,242, 5,247, 5,252, 5,257
Flags
use code U-766
Product numbers
001, 002, 003, 004, 005
19 Mar 2033 · NDA 205122 · TOPIRAMATE
US 8,652,527, product patent
patent.txt lines 5,238, 5,243, 5,248, 5,253, 5,258
Flags
product
Product numbers
001, 002, 003, 004, 005
19 Mar 2033 · NDA 205122 · TOPIRAMATE
US 8,889,190, product patent
patent.txt lines 5,239, 5,244, 5,249, 5,254, 5,259
Flags
product
Product numbers
001, 002, 003, 004, 005
19 Mar 2033 · NDA 205122 · TOPIRAMATE
US 9,101,545, product patent
patent.txt lines 5,240, 5,245, 5,250, 5,255, 5,260
Flags
product
Product numbers
001, 002, 003, 004, 005
19 Mar 2033 · NDA 205122 · TOPIRAMATE
US 9,555,005, product patent
patent.txt lines 5,241, 5,246, 5,251, 5,256, 5,261
Flags
product
Product numbers
001, 002, 003, 004, 005
21 Mar 2033 · NDA 212819 · CILASTATIN SODIUM; IMIPENEM; RELEBACTAM
US 8,487,093, substance and product and use patent
patent.txt line 14,430
Flags
substance product use code U-2586
Product numbers
001
21 Mar 2033 · NDA 212819 · CILASTATIN SODIUM; IMIPENEM; RELEBACTAM
US 8,487,093, substance and product and use patent
patent.txt line 14,431
Flags
substance product use code U-2587
Product numbers
001
21 Mar 2033 · NDA 212819 · CILASTATIN SODIUM; IMIPENEM; RELEBACTAM
US 8,487,093, substance and product and use patent
patent.txt line 14,432
Flags
substance product use code U-2840
Product numbers
001
22 Mar 2033 · NDA 219019 · FITUSIRAN SODIUM
US 9,127,274, substance and product and use patent
patent.txt lines 21,460, 21,464
Flags
substance product use code U-4165
Product numbers
001, 002
22 Mar 2033 · NDA 219019 · FITUSIRAN SODIUM
US RE50996, substance and product and use patent
patent.txt lines 21,462, 21,466
Flags
substance product use code U-4165
Product numbers
001, 002
24 Mar 2033 · NDA 209899 · OZANIMOD HYDROCHLORIDE
US 8,481,573, substance and product and use patent
patent.txt lines 11,003, 11,009, 11,015
Flags
substance product use code U-2774
Product numbers
001, 002, 003
25 Mar 2033 · NDA 211672 · LEFAMULIN ACETATE
US 8,071,643, substance and product patent
patent.txt line 12,966
Flags
substance product
Product numbers
001
25 Mar 2033 · NDA 211673 · LEFAMULIN ACETATE
US 8,071,643, substance and product patent
patent.txt line 12,970
Flags
substance product
Product numbers
001
25 Mar 2033 · NDA 212099 · DAROLUTAMIDE
US 8,975,254, substance and product and use patent
patent.txt line 13,543
Flags
substance product use code U-4208
Product numbers
001
25 Mar 2033 · NDA 212099 · DAROLUTAMIDE
US 8,975,254, substance and product and use patent
patent.txt line 13,544
Flags
substance product use code U-4209
Product numbers
001
25 Mar 2033 · NDA 212099 · DAROLUTAMIDE
US 8,975,254, substance and product and use patent
patent.txt line 13,545
Flags
substance product use code U-4210
Product numbers
001
25 Mar 2033 · NDA 213411 · TUCATINIB
US 11,504,370, use patent
patent.txt lines 14,983, 14,990
Flags
use code U-2788
Product numbers
001, 002
31 Mar 2033 · NDA 207233 · MELOXICAM
US 9,526,734, product patent
patent.txt lines 7,224, 7,228
Flags
product
Product numbers
001, 002
2 Apr 2033 · NDA 216974 · DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM
US 9,309,245, substance patent
patent.txt line 19,090
Flags
substance
Product numbers
001
2 Apr 2033 · NDA 216974 · DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM
US 9,623,014, use patent
patent.txt line 19,091
Flags
use code U-2840
Product numbers
001
5 Apr 2033 · NDA 213586 · RISPERIDONE
US 9,023,897, product patent
patent.txt lines 15,095, 15,104, 15,113, 15,119, 15,125, 15,131, 15,137
Flags
product
Product numbers
001, 002, 003, 004, 005, 006, 007
7 Apr 2033 · NDA 205677 · TASIMELTEON
US 11,918,556, use patent
patent.txt line 5,793
Flags
use code U-3342
Product numbers
001
7 Apr 2033 · NDA 205677 · TASIMELTEON
US 11,918,556, use patent
patent.txt line 5,794
Flags
use code U-3343
Product numbers
001
7 Apr 2033 · NDA 211158 · TIGECYCLINE
US 9,855,335, product patent
patent.txt line 12,506
Flags
product
Product numbers
001
7 Apr 2033 · NDA 214517 · TASIMELTEON
US 11,918,556, use patent
patent.txt line 15,855
Flags
use code U-3342
Product numbers
001
9 Apr 2033 · NDA 218201 · COPPER
US 9,089,418, product patent
patent.txt line 20,901
Flags
product
Product numbers
001
11 Apr 2033 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 10,245,269, use patent
patent.txt line 13,088
Flags
use code U-2737
Product numbers
001
11 Apr 2033 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 10,245,269, use patent
patent.txt line 13,089
Flags
use code U-2851
Product numbers
001
11 Apr 2033 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 10,245,269, use patent
patent.txt line 13,090
Flags
use code U-2854
Product numbers
001
11 Apr 2033 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 10,821,113, substance and product patent
patent.txt line 13,098
Flags
substance product
Product numbers
001
11 Apr 2033 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 11,491,163, use patent
patent.txt line 13,102
Flags
use code U-2736
Product numbers
001
11 Apr 2033 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 11,491,163, use patent
patent.txt line 13,103
Flags
use code U-2852
Product numbers
001
11 Apr 2033 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 11,491,163, use patent
patent.txt line 13,104
Flags
use code U-2853
Product numbers
001
11 Apr 2033 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 9,394,283, substance and product and use patent
patent.txt line 13,122
Flags
substance product use code U-2852
Product numbers
001
11 Apr 2033 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 9,394,283, substance and product and use patent
patent.txt line 13,123
Flags
substance product use code U-2853
Product numbers
001
12 Apr 2033 · NDA 212018 · ERDAFITINIB
US 8,895,601, substance and product patent
patent.txt lines 13,397, 13,415, 13,433
Flags
substance product
Product numbers
001, 002, 003
12 Apr 2033 · NDA 216196 · MITAPIVAT SULFATE
US 11,793,806, use patent
patent.txt lines 18,435, 18,444, 18,453
Flags
use code U-3320
Product numbers
001, 002, 003
16 Apr 2033 · NDA 218197 · CAPIVASERTIB
US 10,039,766, use patent
patent.txt lines 20,872, 20,882
Flags
use code U-3762
Product numbers
001, 002
16 Apr 2033 · NDA 218197 · CAPIVASERTIB
US 10,039,766, use patent
patent.txt lines 20,873, 20,883
Flags
use code U-4559
Product numbers
001, 002
16 Apr 2033 · NDA 218197 · CAPIVASERTIB
US 9,487,525, substance and product patent
patent.txt lines 20,880, 20,890
Flags
substance product
Product numbers
001, 002
22 Apr 2033 · NDA 204629 · EMPAGLIFLOZIN
US 12,527,810, use patent
patent.txt lines 4,898, 4,929
Flags
use code U-4403
Product numbers
001, 002
22 Apr 2033 · NDA 206111 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 12,527,810, use patent
patent.txt lines 6,313, 6,344, 6,373, 6,402
Flags
use code U-4403
Product numbers
001, 002, 003, 004
23 Apr 2033 · NDA 217006 · ARIPIPRAZOLE
US 10,517,951, product and use patent
patent.txt lines 19,233, 19,241
Flags
product use code U-3245
Product numbers
001, 002
23 Apr 2033 · NDA 217006 · ARIPIPRAZOLE
US 10,517,951, product and use patent
patent.txt lines 19,234, 19,242
Flags
product use code U-814
Product numbers
001, 002
23 Apr 2033 · NDA 217006 · ARIPIPRAZOLE
US 11,097,007, product and use patent
patent.txt lines 19,235, 19,243
Flags
product use code U-3245
Product numbers
001, 002
23 Apr 2033 · NDA 217006 · ARIPIPRAZOLE
US 11,097,007, product and use patent
patent.txt lines 19,236, 19,244
Flags
product use code U-814
Product numbers
001, 002
23 Apr 2033 · NDA 217006 · ARIPIPRAZOLE
US 11,638,757, product and use patent
patent.txt lines 19,237, 19,245
Flags
product use code U-3245
Product numbers
001, 002
23 Apr 2033 · NDA 217006 · ARIPIPRAZOLE
US 11,638,757, product and use patent
patent.txt lines 19,238, 19,246
Flags
product use code U-814
Product numbers
001, 002
23 Apr 2033 · NDA 217006 · ARIPIPRAZOLE
US 12,016,927, product and use patent
patent.txt lines 19,239, 19,247
Flags
product use code U-3245
Product numbers
001, 002
23 Apr 2033 · NDA 217006 · ARIPIPRAZOLE
US 12,016,927, product and use patent
patent.txt lines 19,240, 19,248
Flags
product use code U-543
Product numbers
001, 002
24 Apr 2033 · NDA 216718 · OMAVELOXOLONE
US 8,993,640, substance and product patent
patent.txt line 18,929
Flags
substance product
Product numbers
001
24 Apr 2033 · NDA 216718 · OMAVELOXOLONE
US 9,701,709, substance and product patent
patent.txt line 18,931
Flags
substance product
Product numbers
001
29 Apr 2033 · NDA 212526 · ALPELISIB
US 8,227,462, substance and product and use patent
patent.txt lines 14,147, 14,149, 14,151
Flags
substance product use code U-3809
Product numbers
001, 002, 003
29 Apr 2033 · NDA 215039 · ALPELISIB
US 8,227,462, substance and product patent
patent.txt lines 16,447, 16,451, 16,455
Flags
substance product
Product numbers
001, 002, 003
29 Apr 2033 · NDA 218466 · ALPELISIB
US 8,227,462, substance and product patent
patent.txt line 21,090
Flags
substance product
Product numbers
001
30 Apr 2033 · NDA 212295 · REMIMAZOLAM BESYLATE
US 9,561,236, use patent
patent.txt line 13,804
Flags
use code U-2968
Product numbers
001
1 May 2033 · NDA 213072 · EZETIMIBE; ROSUVASTATIN CALCIUM
US 10,376,470, product and use patent
patent.txt lines 14,652, 14,654, 14,656, 14,658
Flags
product use code U-3095
Product numbers
001, 002, 003, 004
1 May 2033 · NDA 213072 · EZETIMIBE; ROSUVASTATIN CALCIUM
US 9,763,885, product and use patent
patent.txt lines 14,653, 14,655, 14,657, 14,659
Flags
product use code U-3095
Product numbers
001, 002, 003, 004
3 May 2033 · NDA 210565 · LOTEPREDNOL ETABONATE
US 10,058,511, product and use patent
patent.txt line 12,011
Flags
product use code U-2492
Product numbers
001
3 May 2033 · NDA 210565 · LOTEPREDNOL ETABONATE
US 10,646,437, product patent
patent.txt line 12,012
Flags
product
Product numbers
001
3 May 2033 · NDA 210565 · LOTEPREDNOL ETABONATE
US 10,688,045, product patent
patent.txt line 12,013
Flags
product
Product numbers
001
3 May 2033 · NDA 210565 · LOTEPREDNOL ETABONATE
US 10,864,219, use patent
patent.txt line 12,014
Flags
use code U-3011
Product numbers
001
3 May 2033 · NDA 210565 · LOTEPREDNOL ETABONATE
US 11,219,597, use patent
patent.txt line 12,015
Flags
use code U-3278
Product numbers
001
3 May 2033 · NDA 210565 · LOTEPREDNOL ETABONATE
US 11,219,597, use patent
patent.txt line 12,016
Flags
use code U-3279
Product numbers
001
3 May 2033 · NDA 210565 · LOTEPREDNOL ETABONATE
US 11,642,317, product patent
patent.txt line 12,017
Flags
product
Product numbers
001
3 May 2033 · NDA 210565 · LOTEPREDNOL ETABONATE
US 11,872,318, product patent
patent.txt line 12,018
Flags
product
Product numbers
001
3 May 2033 · NDA 210565 · LOTEPREDNOL ETABONATE
US 12,115,246, product and use patent
patent.txt line 12,019
Flags
product use code U-4025
Product numbers
001
3 May 2033 · NDA 210565 · LOTEPREDNOL ETABONATE
US 9,056,057, product and use patent
patent.txt line 12,020
Flags
product use code U-2491
Product numbers
001
3 May 2033 · NDA 210565 · LOTEPREDNOL ETABONATE
US 9,393,213, product patent
patent.txt line 12,021
Flags
product
Product numbers
001
3 May 2033 · NDA 210565 · LOTEPREDNOL ETABONATE
US 9,532,955, use patent
patent.txt line 12,022
Flags
use code U-2491
Product numbers
001
3 May 2033 · NDA 210565 · LOTEPREDNOL ETABONATE
US 9,737,491, use patent
patent.txt line 12,023
Flags
use code U-2492
Product numbers
001
3 May 2033 · NDA 210565 · LOTEPREDNOL ETABONATE
US 9,827,191, product and use patent
patent.txt line 12,024
Flags
product use code U-2493
Product numbers
001
3 May 2033 · NDA 210933 · LOTEPREDNOL ETABONATE
US 10,058,511, product and use patent
patent.txt line 12,410
Flags
product use code U-2492
Product numbers
001
3 May 2033 · NDA 210933 · LOTEPREDNOL ETABONATE
US 10,646,436, product patent
patent.txt line 12,411
Flags
product
Product numbers
001
3 May 2033 · NDA 210933 · LOTEPREDNOL ETABONATE
US 10,688,045, product patent
patent.txt line 12,412
Flags
product
Product numbers
001
3 May 2033 · NDA 210933 · LOTEPREDNOL ETABONATE
US 10,857,096, use patent
patent.txt line 12,413
Flags
use code U-2985
Product numbers
001
3 May 2033 · NDA 210933 · LOTEPREDNOL ETABONATE
US 10,940,108, use patent
patent.txt line 12,414
Flags
use code U-2985
Product numbers
001
3 May 2033 · NDA 210933 · LOTEPREDNOL ETABONATE
US 10,945,948, use patent
patent.txt line 12,415
Flags
use code U-2985
Product numbers
001
3 May 2033 · NDA 210933 · LOTEPREDNOL ETABONATE
US 10,993,908, use patent
patent.txt line 12,416
Flags
use code U-3117
Product numbers
001
3 May 2033 · NDA 210933 · LOTEPREDNOL ETABONATE
US 11,219,596, use patent
patent.txt line 12,417
Flags
use code U-2985
Product numbers
001
3 May 2033 · NDA 210933 · LOTEPREDNOL ETABONATE
US 11,596,599, use patent
patent.txt line 12,418
Flags
use code U-2985
Product numbers
001
3 May 2033 · NDA 210933 · LOTEPREDNOL ETABONATE
US 11,642,317, product patent
patent.txt line 12,419
Flags
product
Product numbers
001
3 May 2033 · NDA 210933 · LOTEPREDNOL ETABONATE
US 11,872,318, product patent
patent.txt line 12,420
Flags
product
Product numbers
001
3 May 2033 · NDA 210933 · LOTEPREDNOL ETABONATE
US 12,115,246, product and use patent
patent.txt line 12,421
Flags
product use code U-2985
Product numbers
001
3 May 2033 · NDA 210933 · LOTEPREDNOL ETABONATE
US 9,056,057, product and use patent
patent.txt line 12,422
Flags
product use code U-2491
Product numbers
001
3 May 2033 · NDA 210933 · LOTEPREDNOL ETABONATE
US 9,393,213, product patent
patent.txt line 12,423
Flags
product
Product numbers
001
3 May 2033 · NDA 210933 · LOTEPREDNOL ETABONATE
US 9,532,955, use patent
patent.txt line 12,424
Flags
use code U-2491
Product numbers
001
3 May 2033 · NDA 210933 · LOTEPREDNOL ETABONATE
US 9,737,491, use patent
patent.txt line 12,425
Flags
use code U-2492
Product numbers
001
3 May 2033 · NDA 210933 · LOTEPREDNOL ETABONATE
US 9,827,191, product and use patent
patent.txt line 12,426
Flags
product use code U-2985
Product numbers
001
3 May 2033 · NDA 212102 · FENFLURAMINE HYDROCHLORIDE
US 10,478,441, use patent
patent.txt line 13,552
Flags
use code U-2860
Product numbers
001
3 May 2033 · NDA 212102 · FENFLURAMINE HYDROCHLORIDE
US 10,478,442, use patent
patent.txt line 13,554
Flags
use code U-2860
Product numbers
001
3 May 2033 · NDA 212102 · FENFLURAMINE HYDROCHLORIDE
US 12,097,206, use patent
patent.txt line 13,571
Flags
use code U-4013
Product numbers
001
3 May 2033 · NDA 212102 · FENFLURAMINE HYDROCHLORIDE
US 9,549,909, use patent
patent.txt line 13,573
Flags
use code U-2858
Product numbers
001
3 May 2033 · NDA 212102 · FENFLURAMINE HYDROCHLORIDE
US 9,603,814, use patent
patent.txt line 13,575
Flags
use code U-2858
Product numbers
001
3 May 2033 · NDA 212102 · FENFLURAMINE HYDROCHLORIDE
US 9,603,815, use patent
patent.txt line 13,577
Flags
use code U-2858
Product numbers
001
3 May 2033 · NDA 212102 · FENFLURAMINE HYDROCHLORIDE
US 9,610,260, use patent
patent.txt line 13,579
Flags
use code U-2858
Product numbers
001
4 May 2033 · NDA 211810 · PEXIDARTINIB HYDROCHLORIDE
US 7,893,075, substance patent
patent.txt lines 13,194, 13,206
Flags
substance
Product numbers
001, 002
9 May 2033 · NDA 215888 · OTESECONAZOLE
US 11,247,981, use patent
patent.txt line 18,075
Flags
use code U-3366
Product numbers
001
13 May 2033 · NDA 208854 · NALDEMEDINE TOSYLATE
US 10,952,968, substance and product patent
patent.txt line 9,579
Flags
substance product
Product numbers
001
13 May 2033 · NDA 208854 · NALDEMEDINE TOSYLATE
US 12,350,377, product patent
patent.txt line 9,580
Flags
product
Product numbers
001
15 May 2033 · NDA 202833 · INGENOL MEBUTATE
US 9,789,078, use patent
patent.txt line 3,386
Flags
use code U-2138
Product numbers
001
16 May 2033 · NDA 208437 · GLYCOPYRROLATE
US 9,604,018, product patent
patent.txt line 8,628
Flags
product
Product numbers
001
20 May 2033 · NDA 212801 · OSILODROSTAT PHOSPHATE
US 8,314,097, substance and product patent
patent.txt lines 14,414, 14,420
Flags
substance product
Product numbers
001, 002
22 May 2033 · NDA 212725 · ENTRECTINIB
US 9,085,565, substance and product patent
patent.txt lines 14,382, 14,401
Flags
substance product
Product numbers
001, 002
22 May 2033 · NDA 212725 · ENTRECTINIB
US 9,649,306, use patent
patent.txt lines 14,386, 14,405
Flags
use code U-2617
Product numbers
001, 002
22 May 2033 · NDA 212725 · ENTRECTINIB
US 9,649,306, use patent
patent.txt lines 14,387, 14,406
Flags
use code U-2618
Product numbers
001, 002
24 May 2033 · NDA 220641 · RELACORILANT
US 10,456,392, use patent
patent.txt line 22,363
Flags
use code U-4457
Product numbers
001
24 May 2033 · NDA 220641 · RELACORILANT
US 11,576,907, substance and product and use patent
patent.txt line 22,368
Flags
substance product use code U-4457
Product numbers
001
24 May 2033 · NDA 220641 · RELACORILANT
US 11,576,907, substance and product and use patent
patent.txt line 22,369
Flags
substance product use code U-4458
Product numbers
001
24 May 2033 · NDA 220641 · RELACORILANT
US 11,576,907, substance and product and use patent
patent.txt line 22,370
Flags
substance product use code U-4459
Product numbers
001
24 May 2033 · NDA 220641 · RELACORILANT
US 8,859,774, substance and product patent
patent.txt line 22,379
Flags
substance product
Product numbers
001
24 May 2033 · NDA 220641 · RELACORILANT
US 9,273,047, use patent
patent.txt line 22,380
Flags
use code U-4457
Product numbers
001
24 May 2033 · NDA 220641 · RELACORILANT
US 9,273,047, use patent
patent.txt line 22,381
Flags
use code U-4458
Product numbers
001
24 May 2033 · NDA 220641 · RELACORILANT
US 9,273,047, use patent
patent.txt line 22,382
Flags
use code U-4459
Product numbers
001
29 May 2033 · NDA 204569 · SUVOREXANT
US 10,098,892, product patent
patent.txt lines 4,826, 4,830, 4,834, 4,838
Flags
product
Product numbers
001, 002, 003, 004
29 May 2033 · NDA 204569 · SUVOREXANT
US 11,980,623, product patent
patent.txt lines 4,827, 4,831, 4,835, 4,839
Flags
product
Product numbers
001, 002, 003, 004
29 May 2033 · NDA 204569 · SUVOREXANT
US 12,599,610, product patent
patent.txt lines 4,828, 4,832, 4,836, 4,840
Flags
product
Product numbers
001, 002, 003, 004
30 May 2033 · NDA 211527 · TRIFAROTENE
US 9,084,778, product and use patent
patent.txt line 12,880
Flags
product use code U-134
Product numbers
001
30 May 2033 · NDA 211527 · TRIFAROTENE
US 9,498,465, product and use patent
patent.txt line 12,881
Flags
product use code U-1033
Product numbers
001
31 May 2033 · NDA 021695 · FENOFIBRATE
US 9,314,447, product and use patent
patent.txt line 681
Flags
product use code U-1447
Product numbers
005
31 May 2033 · NDA 021695 · FENOFIBRATE
US 9,314,447, product and use patent
patent.txt line 682
Flags
product use code U-1448
Product numbers
005
31 May 2033 · NDA 213378 · OLANZAPINE; SAMIDORPHAN L-MALATE
US 10,300,054, product and use patent
patent.txt lines 14,884, 14,905, 14,926, 14,947
Flags
product use code U-3140
Product numbers
001, 002, 003, 004
31 May 2033 · NDA 213378 · OLANZAPINE; SAMIDORPHAN L-MALATE
US 10,300,054, product and use patent
patent.txt lines 14,885, 14,906, 14,927, 14,948
Flags
product use code U-3141
Product numbers
001, 002, 003, 004
3 Jun 2033 · NDA 205552 · IBRUTINIB
US 10,106,548, substance and product patent
patent.txt lines 5,475, 5,574
Flags
substance product
Product numbers
001, 002
3 Jun 2033 · NDA 205552 · IBRUTINIB
US 10,125,140, substance and product patent
patent.txt lines 5,477, 5,576
Flags
substance product
Product numbers
001, 002
3 Jun 2033 · NDA 205552 · IBRUTINIB
US 10,294,231, product patent
patent.txt lines 5,479, 5,578
Flags
product
Product numbers
001, 002
3 Jun 2033 · NDA 205552 · IBRUTINIB
US 10,294,232, product patent
patent.txt lines 5,481, 5,580
Flags
product
Product numbers
001, 002
3 Jun 2033 · NDA 205552 · IBRUTINIB
US 10,752,634, product patent
patent.txt line 5,500
Flags
product
Product numbers
001
3 Jun 2033 · NDA 205552 · IBRUTINIB
US 10,961,251, product patent
patent.txt lines 5,502, 5,599
Flags
product
Product numbers
001, 002
3 Jun 2033 · NDA 205552 · IBRUTINIB
US 9,713,617, product patent
patent.txt lines 5,554, 5,652
Flags
product
Product numbers
001, 002
3 Jun 2033 · NDA 205552 · IBRUTINIB
US 9,725,455, substance patent
patent.txt lines 5,556, 5,654
Flags
substance
Product numbers
001, 002
3 Jun 2033 · NDA 210563 · IBRUTINIB
US 10,106,548, substance and product patent
patent.txt lines 11,597, 11,703, 11,807, 11,911
Flags
substance product
Product numbers
001, 002, 003, 004
3 Jun 2033 · NDA 210563 · IBRUTINIB
US 10,125,140, substance and product patent
patent.txt lines 11,599, 11,705, 11,809, 11,913
Flags
substance product
Product numbers
001, 002, 003, 004
3 Jun 2033 · NDA 210563 · IBRUTINIB
US 10,752,634, product patent
patent.txt line 11,620
Flags
product
Product numbers
001
3 Jun 2033 · NDA 210563 · IBRUTINIB
US 10,961,251, product patent
patent.txt lines 11,624, 11,728, 11,832, 11,939
Flags
product
Product numbers
001, 002, 003, 004
3 Jun 2033 · NDA 210563 · IBRUTINIB
US 9,725,455, substance patent
patent.txt lines 11,682, 11,786, 11,890, 11,999
Flags
substance
Product numbers
001, 002, 003, 004
3 Jun 2033 · NDA 214985 · DARIDOREXANT HYDROCHLORIDE
US 9,732,075, substance and product and use patent
patent.txt lines 16,404, 16,407
Flags
substance product use code U-620
Product numbers
001, 002
3 Jun 2033 · NDA 217003 · IBRUTINIB
US 10,106,548, substance and product patent
patent.txt line 19,153
Flags
substance product
Product numbers
001
3 Jun 2033 · NDA 217003 · IBRUTINIB
US 10,125,140, substance and product patent
patent.txt line 19,155
Flags
substance product
Product numbers
001
3 Jun 2033 · NDA 217003 · IBRUTINIB
US 10,961,251, product patent
patent.txt line 19,171
Flags
product
Product numbers
001
3 Jun 2033 · NDA 217003 · IBRUTINIB
US 9,725,455, substance patent
patent.txt line 19,223
Flags
substance
Product numbers
001
3 Jun 2033 · NDA 219713 · TALETRECTINIB ADIPATE
US 9,187,489, substance and product and use patent
patent.txt line 21,872
Flags
substance product use code U-4207
Product numbers
001
3 Jun 2033 · NDA 219713 · TALETRECTINIB ADIPATE
US 9,751,887, substance and product and use patent
patent.txt line 21,873
Flags
substance product use code U-4207
Product numbers
001
4 Jun 2033 · NDA 209863 · TESTOSTERONE ENANTHATE
US 10,821,072, product and use patent
patent.txt lines 10,920, 10,943, 10,966
Flags
product use code U-2418
Product numbers
001, 002, 003
4 Jun 2033 · NDA 209863 · TESTOSTERONE ENANTHATE
US 11,844,804, use patent
patent.txt lines 10,930, 10,953, 10,976
Flags
use code U-2418
Product numbers
001, 002, 003
4 Jun 2033 · NDA 210951 · APALUTAMIDE
US 9,481,663, substance and product and use patent
patent.txt lines 12,445, 12,463
Flags
substance product use code U-2237
Product numbers
001, 002
4 Jun 2033 · NDA 210951 · APALUTAMIDE
US 9,481,663, substance and product and use patent
patent.txt lines 12,446, 12,464
Flags
substance product use code U-2624
Product numbers
001, 002
5 Jun 2033 · NDA 200063 · BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US 10,403,170, use patent
patent.txt line 2,199
Flags
use code U-1583
Product numbers
001
5 Jun 2033 · NDA 200063 · BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US 11,139,056, use patent
patent.txt line 2,203
Flags
use code U-1583
Product numbers
001
8 Jun 2033 · NDA 211810 · PEXIDARTINIB HYDROCHLORIDE
US 9,358,235, use patent
patent.txt lines 13,199, 13,211
Flags
use code U-2606
Product numbers
001, 002
12 Jun 2033 · NDA 207793 · IRINOTECAN HYDROCHLORIDE
US 10,980,795, use patent
patent.txt line 7,416
Flags
use code U-1848
Product numbers
001
12 Jun 2033 · NDA 207793 · IRINOTECAN HYDROCHLORIDE
US 11,369,597, use patent
patent.txt line 7,419
Flags
use code U-1848
Product numbers
001
12 Jun 2033 · NDA 207793 · IRINOTECAN HYDROCHLORIDE
US 12,364,691, use patent
patent.txt line 7,421
Flags
use code U-1848
Product numbers
001
12 Jun 2033 · NDA 207793 · IRINOTECAN HYDROCHLORIDE
US 9,339,497, use patent
patent.txt line 7,424
Flags
use code U-1848
Product numbers
001
12 Jun 2033 · NDA 207793 · IRINOTECAN HYDROCHLORIDE
US 9,364,473, use patent
patent.txt line 7,425
Flags
use code U-1856
Product numbers
001
12 Jun 2033 · NDA 207793 · IRINOTECAN HYDROCHLORIDE
US 9,452,162, use patent
patent.txt line 7,426
Flags
use code U-1899
Product numbers
001
12 Jun 2033 · NDA 207793 · IRINOTECAN HYDROCHLORIDE
US 9,492,442, use patent
patent.txt line 7,427
Flags
use code U-1848
Product numbers
001
12 Jun 2033 · NDA 207793 · IRINOTECAN HYDROCHLORIDE
US 9,492,442, use patent
patent.txt line 7,428
Flags
use code U-1899
Product numbers
001
12 Jun 2033 · NDA 207793 · IRINOTECAN HYDROCHLORIDE
US 9,492,442, use patent
patent.txt line 7,429
Flags
use code U-1917
Product numbers
001
12 Jun 2033 · NDA 207793 · IRINOTECAN HYDROCHLORIDE
US 9,717,724, use patent
patent.txt line 7,430
Flags
use code U-1848
Product numbers
001
12 Jun 2033 · NDA 207793 · IRINOTECAN HYDROCHLORIDE
US 9,717,724, use patent
patent.txt line 7,431
Flags
use code U-2091
Product numbers
001
17 Jun 2033 · NDA 207999 · OBETICHOLIC ACID
US 10,174,073, substance patent
patent.txt lines 7,936, 7,943
Flags
substance
Product numbers
001, 002
17 Jun 2033 · NDA 207999 · OBETICHOLIC ACID
US 9,238,673, product patent
patent.txt lines 7,939, 7,946
Flags
product
Product numbers
001, 002
19 Jun 2033 · NDA 208183 · HALOBETASOL PROPIONATE
US 8,962,028, product and use patent
patent.txt line 8,296
Flags
product use code U-1775
Product numbers
001
19 Jun 2033 · NDA 213051 · SEMAGLUTIDE
US 11,033,499, product and use patent
patent.txt lines 14,583, 14,598, 14,613, 14,625, 14,634, 14,643
Flags
product use code U-2628
Product numbers
001, 002, 003, 004, 005, 006
19 Jun 2033 · NDA 218316 · SEMAGLUTIDE
US 11,033,499, product and use patent
patent.txt lines 20,934, 20,942, 20,950, 20,959
Flags
product use code U-4496
Product numbers
001, 002, 003, 004
21 Jun 2033 · NDA 208901 · ITRACONAZOLE
US 10,463,740, product and use patent
patent.txt line 9,584
Flags
product use code U-2453
Product numbers
001
21 Jun 2033 · NDA 208901 · ITRACONAZOLE
US 10,806,792, product patent
patent.txt line 9,585
Flags
product
Product numbers
001
21 Jun 2033 · NDA 208901 · ITRACONAZOLE
US 8,921,374, product patent
patent.txt line 9,586
Flags
product
Product numbers
001
21 Jun 2033 · NDA 208901 · ITRACONAZOLE
US 9,272,046, product patent
patent.txt line 9,587
Flags
product
Product numbers
001
21 Jun 2033 · NDA 208901 · ITRACONAZOLE
US 9,713,642, use patent
patent.txt line 9,588
Flags
use code U-2453
Product numbers
001
21 Jun 2033 · NDA 209637 · SEMAGLUTIDE
US 10,335,462, use patent
patent.txt lines 10,687, 10,703
Flags
use code U-2580
Product numbers
001, 002
21 Jun 2033 · NDA 209637 · SEMAGLUTIDE
US 10,335,462, product and use patent
patent.txt line 10,738
Flags
product use code U-2580
Product numbers
004
21 Jun 2033 · NDA 209637 · SEMAGLUTIDE
US 10,335,462, use patent
patent.txt line 10,769
Flags
use code U-1852
Product numbers
007
21 Jun 2033 · NDA 215256 · SEMAGLUTIDE
US 9,764,003, use patent
patent.txt lines 16,610, 16,618, 16,626, 16,634, 16,644, 16,664, 16,676, 16,688, 16,700, 16,712, 16,717
Flags
use code U-3161
Product numbers
001, 002, 003, 004, 005, 007, 008, 009, 010, 011, 012
21 Jun 2033 · NDA 215256 · SEMAGLUTIDE
US 9,764,003, use patent
patent.txt line 16,652
Flags
use code U-4418
Product numbers
006
25 Jun 2033 · NDA 200063 · BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US 9,633,575, use patent
patent.txt line 2,214
Flags
use code U-1583
Product numbers
001
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 10,278,935, use patent
patent.txt lines 2,622, 2,685
Flags
use code U-2701
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 10,278,936, use patent
patent.txt lines 2,623, 2,686
Flags
use code U-2702
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 10,278,937, use patent
patent.txt lines 2,624, 2,687
Flags
use code U-2703
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 10,383,840, use patent
patent.txt lines 2,625, 2,688
Flags
use code U-2704
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 10,555,924, use patent
patent.txt lines 2,626, 2,689
Flags
use code U-2743
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 10,555,925, use patent
patent.txt lines 2,627, 2,690
Flags
use code U-2744
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 10,568,861, use patent
patent.txt lines 2,628, 2,691
Flags
use code U-2756
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 10,576,054, use patent
patent.txt lines 2,629, 2,692
Flags
use code U-2762
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 10,668,042, use patent
patent.txt lines 2,630, 2,693
Flags
use code U-2841
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 10,786,478, use patent
patent.txt lines 2,631, 2,694
Flags
use code U-2959
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 10,786,478, use patent
patent.txt lines 2,632, 2,695
Flags
use code U-2960
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 10,792,270, use patent
patent.txt lines 2,634, 2,697
Flags
use code U-2962
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 10,894,028, use patent
patent.txt lines 2,638, 2,701
Flags
use code U-3053
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 11,000,499, use patent
patent.txt lines 2,639, 2,702
Flags
use code U-3126
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 11,116,742, use patent
patent.txt lines 2,641, 2,704
Flags
use code U-3221
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 11,298,333, use patent
patent.txt lines 2,644, 2,707
Flags
use code U-3358
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 11,369,582, use patent
patent.txt lines 2,645, 2,708
Flags
use code U-2841
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 9,603,826, use patent
patent.txt lines 2,675, 2,737
Flags
use code U-2696
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 9,610,272, use patent
patent.txt lines 2,676, 2,738
Flags
use code U-2697
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 9,623,001, use patent
patent.txt lines 2,677, 2,739
Flags
use code U-2698
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 9,693,984, use patent
patent.txt lines 2,678, 2,740
Flags
use code U-2697
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 9,693,985, use patent
patent.txt lines 2,679, 2,741
Flags
use code U-2696
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 9,693,986, use patent
patent.txt lines 2,680, 2,742
Flags
use code U-2698
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 9,918,954, use patent
patent.txt lines 2,682, 2,744
Flags
use code U-2699
Product numbers
001, 002

Pediatric exclusivity, as listed (33)

9 Jan 2033 · NDA 208694 · CETIRIZINE HYDROCHLORIDE
US 9,254,286 with pediatric exclusivity, as listed
patent.txt line 9,239
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Feb 2033 · NDA 207561 · COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 8,754,065 with pediatric exclusivity, as listed
patent.txt line 7,356
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Feb 2033 · NDA 207561 · COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 9,296,769 with pediatric exclusivity, as listed
patent.txt line 7,360
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Feb 2033 · NDA 208215 · EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 8,754,065 with pediatric exclusivity, as listed
patent.txt lines 8,335, 8,344
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
15 Feb 2033 · NDA 208215 · EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 9,296,769 with pediatric exclusivity, as listed
patent.txt lines 8,339, 8,346
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
15 Feb 2033 · NDA 208351 · EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE
US 8,754,065 with pediatric exclusivity, as listed
patent.txt line 8,543
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Feb 2033 · NDA 208351 · EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE
US 9,296,769 with pediatric exclusivity, as listed
patent.txt line 8,545
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Feb 2033 · NDA 208464 · TENOFOVIR ALAFENAMIDE FUMARATE
US 8,754,065 with pediatric exclusivity, as listed
patent.txt line 8,659
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Feb 2033 · NDA 208464 · TENOFOVIR ALAFENAMIDE FUMARATE
US 9,296,769 with pediatric exclusivity, as listed
patent.txt line 8,663
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Feb 2033 · NDA 210251 · BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 8,754,065 with pediatric exclusivity, as listed
patent.txt lines 11,215, 11,224
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
15 Feb 2033 · NDA 210251 · BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 9,296,769 with pediatric exclusivity, as listed
patent.txt lines 11,218, 11,227
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
7 Mar 2033 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 10,028,963 with pediatric exclusivity, as listed
patent.txt line 6,768
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
7 Mar 2033 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 9,724,353 with pediatric exclusivity, as listed
patent.txt line 6,817
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
14 Mar 2033 · NDA 205834 · LEDIPASVIR; SOFOSBUVIR
US 9,393,256 with pediatric exclusivity, as listed
patent.txt lines 5,938, 5,971
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
14 Mar 2033 · NDA 212477 · LEDIPASVIR; SOFOSBUVIR
US 9,393,256 with pediatric exclusivity, as listed
patent.txt lines 14,011, 14,042
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
6 Apr 2033 · NDA 203094 · COBICISTAT
US 10,039,718 with pediatric exclusivity, as listed
patent.txt lines 3,621, 3,625
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
6 Apr 2033 · NDA 203100 · COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
US 10,039,718 with pediatric exclusivity, as listed
patent.txt line 3,629
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
6 Apr 2033 · NDA 207561 · COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 10,039,718 with pediatric exclusivity, as listed
patent.txt line 7,346
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
12 Apr 2033 · NDA 205422 · BREXPIPRAZOLE
US 10,307,419 with pediatric exclusivity, as listed
patent.txt lines 5,307, 5,320, 5,333, 5,346, 5,359
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005
15 Apr 2033 · NDA 209401 · CYTARABINE; DAUNORUBICIN
US 10,028,912 with pediatric exclusivity, as listed
patent.txt line 10,326
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Apr 2033 · NDA 209401 · CYTARABINE; DAUNORUBICIN
US 10,166,184 with pediatric exclusivity, as listed
patent.txt line 10,329
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Apr 2033 · NDA 209401 · CYTARABINE; DAUNORUBICIN
US 10,835,492 with pediatric exclusivity, as listed
patent.txt line 10,331
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
1 May 2033 · NDA 205065 · SAPROPTERIN DIHYDROCHLORIDE
US 9,216,178 with pediatric exclusivity, as listed
patent.txt lines 5,197, 5,199
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
16 May 2033 · NDA 208341 · SOFOSBUVIR; VELPATASVIR
US 8,575,135 with pediatric exclusivity, as listed
patent.txt lines 8,491, 8,521
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
16 May 2033 · NDA 208341 · SOFOSBUVIR; VELPATASVIR
US 8,921,341 with pediatric exclusivity, as listed
patent.txt lines 8,503, 8,533
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
16 May 2033 · NDA 208341 · SOFOSBUVIR; VELPATASVIR
US 8,940,718 with pediatric exclusivity, as listed
patent.txt lines 8,505, 8,535
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
16 May 2033 · NDA 209195 · SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US 8,575,135 with pediatric exclusivity, as listed
patent.txt line 9,825
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
16 May 2033 · NDA 209195 · SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US 8,921,341 with pediatric exclusivity, as listed
patent.txt line 9,843
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
16 May 2033 · NDA 209195 · SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US 8,940,718 with pediatric exclusivity, as listed
patent.txt line 9,846
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
16 May 2033 · NDA 214187 · SOFOSBUVIR; VELPATASVIR
US 8,575,135 with pediatric exclusivity, as listed
patent.txt lines 15,584, 15,612
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
16 May 2033 · NDA 214187 · SOFOSBUVIR; VELPATASVIR
US 8,921,341 with pediatric exclusivity, as listed
patent.txt lines 15,596, 15,624
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
16 May 2033 · NDA 214187 · SOFOSBUVIR; VELPATASVIR
US 8,940,718 with pediatric exclusivity, as listed
patent.txt lines 15,598, 15,626
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
18 May 2033 · NDA 214787 · REMDESIVIR
US 10,065,958 with pediatric exclusivity, as listed
patent.txt lines 16,121, 16,160
Flags
substance pediatric, as listed by FDA (from the base row)
Product numbers
001, 002

Non-patent exclusivity (11)

12 Jan 2033 · NDA 211241 · COPPER HISTIDINATE
ODE-520 exclusivity
exclusivity.txt line 949
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001
7 Feb 2033 · NDA 217906 · AVIBACTAM SODIUM; AZTREONAM
GAIN exclusivity
exclusivity.txt line 2,027
Definition
Generating Antibiotic Incentives Now (to be checked against FDA's list)
Product numbers
001
12 Feb 2033 · NDA 214012 · INCLISIRAN SODIUM
ODE-555 exclusivity
exclusivity.txt line 1,291
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001
13 Feb 2033 · NDA 211150 · PITOLISANT HYDROCHLORIDE
ODE-519 exclusivity
exclusivity.txt lines 936, 941
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002
27 Feb 2033 · NDA 219164 · NAVEPEGRITIDE
ODE-516 exclusivity
exclusivity.txt lines 2,257, 2,259, 2,261
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002, 003
17 Mar 2033 · NDA 220295 · LINERIXIBAT
ODE-517 exclusivity
exclusivity.txt line 2,382
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001
22 Mar 2033 · NDA 217417 · REZAFUNGIN ACETATE
GAIN exclusivity
exclusivity.txt line 1,873
Definition
Generating Antibiotic Incentives Now (to be checked against FDA's list)
Product numbers
001
27 Mar 2033 · NDA 212273 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
ODE-543 exclusivity
exclusivity.txt lines 1,039, 1,045
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002
27 Mar 2033 · NDA 217660 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
ODE-543 exclusivity
exclusivity.txt lines 1,904, 1,908
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002
27 Mar 2033 · NDA 218730 · DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUM
ODE-536 exclusivity
exclusivity.txt lines 2,181, 2,184
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002
23 May 2033 · NDA 216974 · DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM
GAIN exclusivity
exclusivity.txt line 1,811
Definition
Generating Antibiotic Incentives Now (to be checked against FDA's list)
Product numbers
001